Axogen Inc. (AXGN)
NASDAQ: AXGNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 36.04 0.00%
AXGN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.11B
- Forward P/E
- 52.38
- EPS (TTM)
- -$0.67
- Dividend yield
- None
- Ex-dividend date
- Jan 27, 2010
- 52-week range
- 15.27 – 52.91
- Day range
- 35.83 – 36.88
- Volume / Avg
- 1.60M / 1.22M
- Beta
- —
- Shares outstanding
- 58.67M
- Next earnings
- Nov 4, 2026
52-week range
AXGN stock today
Axogen (AXGN) closed at $36.04 on Oct 7, down 0.74% (-$0.27), versus the S&P 500's 0.22% decline. At this level, AXGN sits in the middle of its 52-week range of $15.27 to $52.91: 31.9% below the high, set on Aug 27, 2026 and 136.0% above the low. AXGN is up 10.1% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 113.3%.
Axogen has posted a net loss over the last twelve months (EPS of -$0.67), so its P/E ratio is not meaningful. Axogen's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Axogen
Company profileAxogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue.
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CEO
- Mr. Michael D. Dale
- Headquarters
- Alachua, FL
- Employees
- 622
- Website
- axogeninc.com
Analyst forecast
ForecastConsensus (11 analysts)
strong_buy
Avg. price target
$53.82+49.33%
- Strong buy 3
- Buy 8
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.03
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $1.00
- Ex-dividend date
- Jan 27, 2010
AXGN news
All AXGN newsAxogen peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TMDXTransMedics Group Inc. | 81.07 | +0.98% | $2.81B | vs AXGN |
| CNMDCONMED Corporation | 44.23 | -0.56% | $1.32B | vs AXGN |
| CBLLCeriBell Inc. | 23.48 | -3.53% | $901.12M | vs AXGN |
| INMDInMode Ltd. | 14.01 | +0.14% | $806.19M | vs AXGN |
| CVCapsoVision Inc. | 6.54 | +0.62% | $348.00M | vs AXGN |
| ELMDElectromed Inc. | 28.20 | -0.25% | $233.70M | vs AXGN |
| FOCLEDAP TMS S.A. ADR | 4.19 | -1.87% | $197.84M | vs AXGN |
| HSDTSolana Company Class A | 2.54 | -4.51% | $165.37M | vs AXGN |
Indexes, lists and sector
Appears in lists
Axogen stock FAQ
What is Axogen's stock price today?
AXGN last traded at $36.04 as of Oct 7, 4:00 PM EDT, down 0.74% on the day. Prices are delayed at least 15 minutes.
Does Axogen pay a dividend?
Yes. Axogen pays $0.00 per share annually. The most recent dividend of $1.00 had an ex-dividend date of Jan 27, 2010.
When is Axogen's next earnings date?
Axogen is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.03.
Who is Axogen's CEO?
Mr. Michael D. Dale is the chief executive officer of Axogen Inc., which has about 622 employees.
Has AXGN ever split its stock?
Yes. The most recent AXGN stock split was a 105-for-100 split on Jul 11, 1994, one of 3 splits on record.
What is the AXGN 52-week high?
The 52-week high for AXGN is $52.91 and the 52-week low is $15.27. The stock is currently 31.9% below its high.